Concomitant Anti-EGFR Antibody (Cetuximab) Plus Hyper-Fractionated Radiotherapy versus Chemotherapy Plus Hyper-Fractionated Radiotherapy in Advanced Non-Metastatic Head and Neck Cancer (Random Controlled Study